These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37165330)

  • 21. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional Disparities in Transplantation With Deceased Donor Kidneys With Kidney Donor Profile Index Less Than 20% Among Candidates With Top 20% Estimated Post Transplant Survival.
    Husain SA; King KL; Dube GK; Tsapepas D; Cohen DJ; Ratner LE; Mohan S
    Prog Transplant; 2019 Dec; 29(4):354-360. PubMed ID: 31506000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.
    Bentley C; Costa S; Burgess MM; Regier D; McTaggart-Cowan H; Peacock SJ
    BMC Health Serv Res; 2018 May; 18(1):339. PubMed ID: 29739463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public preferences for the allocation of donor organs for transplantation: Focus group discussions.
    Oedingen C; Bartling T; Dierks ML; Mühlbacher AC; Schrem H; Krauth C
    Health Expect; 2020 Jun; 23(3):670-680. PubMed ID: 32189453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric deceased donor renal transplantation: An approach to decision making II. Acceptability of a deceased donor kidney for a child, a snap decision at 3 AM.
    Chaudhuri A; Gallo A; Grimm P
    Pediatr Transplant; 2015 Nov; 19(7):785-91. PubMed ID: 26426405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
    Snanoudj R; Kamar N; Cassuto E; Caillard S; Metzger M; Merville P; Thierry A; Jollet I; Grimbert P; Anglicheau D; Hazzan M; Choukroun G; Hurault De Ligny B; Janbon B; Vuiblet V; Devys A; Le Meur Y; Delahousse M; Morelon E; Bailly E; Girerd S; Amokrane K; Legendre C; Hertig A; Rondeau E; Taupin JL
    Kidney Int; 2019 Jun; 95(6):1471-1485. PubMed ID: 30955869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
    Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
    JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
    Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
    Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deceased Donor Characteristics and Kidney Transplant Outcomes.
    Sharif A
    Transpl Int; 2022; 35():10482. PubMed ID: 36090778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrologists' perspectives on waitlisting and allocation of deceased donor kidneys for transplant.
    Tong A; Howard K; Wong G; Cass A; Jan S; Irving M; Craig JC
    Am J Kidney Dis; 2011 Nov; 58(5):704-16. PubMed ID: 21864961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney transplant candidates' and recipients' perspectives on the decision-making process to accept or refuse a deceased donor kidney offer: Trust and graft survival matter.
    Khalili M; Cardinal H; Ballesteros F; Fortin MC
    Clin Transplant; 2022 May; 36(5):e14604. PubMed ID: 35099833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney Donation and Transplant Outcomes in Trinidad and Tobago: A 15-Year Experience of the National Organ Transplant Unit.
    Elcock-Straker B; Manyalich Vidal M; Gomez MP
    Exp Clin Transplant; 2022 Jul; 20(7):649-656. PubMed ID: 35924742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.
    Jani V; Ingulli E; Mekeel K; Morris GP
    Hum Immunol; 2017 Feb; 78(2):72-79. PubMed ID: 27864154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allocation of deceased donor kidneys in São Paulo, Brazil: effect of human leukocyte antigen compatibility on graft survival.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):93-4. PubMed ID: 19249486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New aspects of HLA compatibility in organ transplantation].
    Snanoudj R; Legendre C
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S125-30. PubMed ID: 26968475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Eurotransplant kidney allocation simulations demonstrate the feasibility and benefit of T-cell epitope matching.
    Niemann M; Lachmann N; Geneugelijk K; Spierings E
    PLoS Comput Biol; 2021 Jul; 17(7):e1009248. PubMed ID: 34314431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization.
    Kayler LK; Segev DL
    Am J Kidney Dis; 2010 Jul; 56(1):95-101. PubMed ID: 20347513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype.
    Tambur AR; Das R
    Transplantation; 2023 Mar; 107(3):605-615. PubMed ID: 36163639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.